Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype

作者: A. D. Blann , J. S. Mohan , D. Bareford , G. Y. H. Lip

DOI: 10.1007/S11239-007-0177-7

关键词: EndocrinologyInternal medicineVascular endothelial growth factorNeovascularizationPlatelet activationFibrinolysisCoagulationCoagulopathyMedicineAngiogenesisImmunologyPlateletHematologyCardiology and Cardiovascular Medicine

摘要: Sickle cell disease (SCD) is characterised by abnormal coagulopathy and angiogenesis although their relationships in two common genotypes, homozygous (HbSS) SCD sickle-haemoglobin C (HbSC), are unexplored. We measured markers of platelet activation (soluble P-selectin [sP-selectin]), fibrinolysis (D-dimer) (vascular endothelial growth factor [VEGF]) 27 HbSS patients, 37 HbSC patients 42 age race matched subjects with normal haemoglobin (AA). sP-selectin (P = 0.025) D-dimers < 0.001) were higher than but there was no difference VEGF. In HbSC, sPselectin correlated VEGF 0.012) 0.021). There significant correlations health or HbSS. Platelet coagulation activation, not angiogenic activity, elevated compared to the clinically milder genotype. The correlation between consistent view that released from platelets during vivo activation.

参考文章(27)
M. Detmar, A. M. Dvorak, L. F. Brown, H. F. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology. ,vol. 146, pp. 1029- 1039 ,(1995)
Blood platelets and serum VEGF in cancer patients. British Journal of Cancer. ,vol. 79, pp. 370- 373 ,(1999) , 10.1038/SJ.BJC.6690059
Andrew D Blann, Gregory Y H Lip, D Gareth Beevers, Charles N McCollum, Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thrombosis and Haemostasis. ,vol. 77, pp. 1077- 1080 ,(1997) , 10.1055/S-0038-1656115
Robert P. Hebbel, Stephen H. Embury, Sickle Cell Disease: Basic Principles and Clinical Practice ,(1994)
Werner Risau, Hugo H. Marti, Angiogenesis in ischemic disease. Thrombosis and Haemostasis. ,vol. 82, pp. 44- 52 ,(1999) , 10.1055/S-0037-1615552
R. Mohle, D. Green, M. A. S. Moore, R. L. Nachman, S. Rafii, Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 663- 668 ,(1997) , 10.1073/PNAS.94.2.663
Maxwell P. Westerman, David Green, Alice Gilman-Sachs, Kenneth Beaman, Sally Freels, Lisa Boggio, Sandra Allen, Leon Zuckerman, Robert Schlegel, Patrick Williamson, Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. Journal of Laboratory and Clinical Medicine. ,vol. 134, pp. 352- 362 ,(1999) , 10.1016/S0022-2143(99)90149-X
Aaron Tomer, Laurence A. Harker, Suha Kasey, James R. Eckman, Thrombogenesis in sickle cell disease Journal of Laboratory and Clinical Medicine. ,vol. 137, pp. 398- 407 ,(2001) , 10.1067/MLC.2001.115450
Samir K. Ballas, Cynthia N. Lewis, Ann Marie Noone, Steven H. Krasnow, Embi Kamarulzaman, Edward R. Burka, Clinical, hematological, and biochemical features of Hb SC disease American Journal of Hematology. ,vol. 13, pp. 37- 51 ,(1982) , 10.1002/AJH.2830130106
A. Singhal, P.W. Thomas, B.E. Serjeant, G.R. Serjeant, J.F. Doherty, J.G. Raynes, K.P.W.J. McAdam, Is there an acute-phase response in steady-state sickle cell disease? The Lancet. ,vol. 341, pp. 651- 653 ,(1993) , 10.1016/0140-6736(93)90418-G